Clinitech Laboratory IPO Subscription Status: Clinitech Laboratory IPO is Open on 25 July, 2024 and Close on 29 July, 2024. Clinitech Laboratory IPO to Raise 602,400 shares (Approx ₹5.78 Cr) via IPO. The Fresh Issue of 602,400 shares (Approx ₹5.78 Cr).
- The Retail Quota is 35%
- QIB is 50%
- NII is 15%
Clinitech Laboratory IPO is an SME IPO and Listed on BSE SME. Clinitech Laboratory IPO Price Band is Fixed at ₹96 Equity Share. Clinitech Laboratory IPO Lot Size is 1200 Shares.
About Clinitech Laboratory IPO :
- Clinitech Laboratory is a medical specialty that focuses on the diagnosis of diseases and conditions through the analysis of bodily fluids and tissues. It includes various laboratory tests and techniques such as blood tests, urine analysis, and tissue biopsies to help healthcare professionals understand the underlying causes of a patient’s symptoms and guide treatment decisions. Clinical pathologists play a crucial role in interpreting test results and providing valuable information to aid in patient care. Brief description of various tests conducted at our diagnostic centres.
- Biochemistry plays a crucial role in pathology, the study of disease processes. It helps us understand the molecular and biochemical mechanisms underlying diseases.
Clinitech Laboratory IPO Subscription Status, Rate bid times
Inv Category
Shares Reserved
No. of Shares bid for
No. of Times (Subscription)
Non Institutional Buyers (NIIs)
3,01,200
70,12,800
23.28
Retail Individual Buyers (RIIs)
3,01,200
1,49,41,200
49.61
Market Maker
31,200
31,200
1
Total
5,71,200
2,22,55,200
38.96
Clinitech Laboratory Subscription Status day-by-day-
Categories
25 July
26 July
29 July
QIB
0.00
0.00
0.00
NII
0.62
1.33
23.28
RII
4.33
10.10
49.61
Total
2.61
6.03
38.96
Clinitech Laboratory Investor Categories
- Qualified Institutional Buyers (QIB).
- Non- Institutional Investors (NII).
- Retail individual Investors (RII).
- Employee (EMP).
- Others (Eligible Shareholders).
Who Is QIB In IPO?
QIB Stands For “Qualified Institutional Buyer” In The Context Of An IPO (Initial Public Offering). QIBs Are A Category Of Institutional Investors Who Are Considered Financially Sophisticated And Meet Certain Regulatory Criteria For Participating In Capital Markets. In The Context Of An IPO, QIBs Play A Significant Role As They Contribute To The Overall Demand For Shares And Help Determine The Success Of The Offering.
Who Is NII In IPO?
NII Stands For “Non-Institutional Investors” In The Context Of An IPO (Initial Public Offering). Non-Institutional Investors Are A Category Of Investors Who Participate In The IPO Alongside Institutional Investors And Retail Investors. NII Typically Includes High Net Worth Individuals (HNIs), Corporate Bodies, Trusts, And Other Entities That Are Not Classified As Institutional Investors But Have The Financial Capacity To Invest Significant Amounts In The IPO.
Who Is RII In IPO?
RII Stands For “Retail Individual Investor” In The Context Of An IPO (Initial Public Offering). Retail Individual Investors Are Individual Investors Who Participate In The IPO Alongside Institutional Investors And Non-Institutional Investors. RII Typically Includes Individual Investors Who Do Not Meet The Criteria To Be Classified As Institutional Investors Or Non-Institutional Investors.
Who Is EMP In IPO?
“EMP” In The Context Of An IPO (Initial Public Offering) Typically Stands For “Employee.” In Some IPOs, A Certain Portion Of The Shares May Be Reserved For Allocation To Employees Of The Company Going Public. These Employees Are Often Referred To As “Employee Shareholders” Or “Employee Participants” (EMP).
Clinitech Laboratory Review From MoneyMintIdea –
- May Apply
